The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048).
 
Deborah Schrag
Stock and Other Ownership Interests - Merck (I)
Consulting or Advisory Role - JAMA-Journal of the American Medical Association
Research Funding - AACR (Inst); GRAIL (Inst)
Patents, Royalties, Other Intellectual Property - PRISSMM model is trademarked and curation tools are available to academic medical centers and government under creative commons license.
Other Relationship - JAMA-Journal of the American Medical Association
 
Qian Shi
Honoraria - Chugai Pharma
Consulting or Advisory Role - Hoosier Cancer Research Network; Kronos Bio; Mirati Therapeutics; Regeneron; Yiviva
Research Funding - BMS (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Martin R. Weiser
Consulting or Advisory Role - Precisca
Patents, Royalties, Other Intellectual Property - UpToDate Section Editor
 
Marc J Gollub
Stock and Other Ownership Interests - Pfizer
 
Leonard B. Saltz
Consulting or Advisory Role - Genor BioPharma
 
Benjamin Leon Musher
Consulting or Advisory Role - Exelixis
Speakers' Bureau - Ipsen
Research Funding - Lokon Pharma; Merck
Expert Testimony - AstraZeneca
 
Joel Goldberg
Stock and Other Ownership Interests - Vertex
Honoraria - LM Education and Exchange Services
Consulting or Advisory Role - Institute for Surgical Excellence
Research Funding - Genentech (I)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Tareq Al Baghdadi
Stock and Other Ownership Interests - Bristol-Myers Squibb; Epizyme; HERON
Honoraria - Cardinal Health
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Cardinal Health; Genentech/Roche; Kite, a Gilead company; Lilly
 
Karyn A. Goodman
Consulting or Advisory Role - Novartis; Philips Healthcare; RenovoRx; Roche/Genentech
Other Relationship - National Cancer Institute
 
Robert R. McWilliams
Stock and Other Ownership Interests - Zentalis
Consulting or Advisory Role - Zentalis
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline/Tesaro (Inst); Merck (Inst); Newlink Genetics (Inst)
 
Jeffrey M. Farma
Stock and Other Ownership Interests - Genmab
Expert Testimony - Legal firms
 
Thomas J. George
Consulting or Advisory Role - BillionToOne; Pfizer/Array; Tempus
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BillionToOne (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Elicio Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Merck (Inst); OncoC4 (Inst); Seagen (Inst)
 
Hagen Fritz Kennecke
Honoraria - Natera; Novartis; Tersera
Consulting or Advisory Role - Tersera
Speakers' Bureau - Natera
Research Funding - Exelixis (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Alan P. Venook
Consulting or Advisory Role - Amgen; Bayer Health; BridgeBio Pharma; Bristol-Myers Squibb Foundation/Janssen; Exact Sciences; Exelixis; Gilead Sciences; GlaxoSmithKline; Merck Sharp & Dohme; Pfizer
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
 
Eileen Mary O'Reilly
Consulting or Advisory Role - AstraZeneca; Autem Medical (I); Boehringer Ingelheim; Eisai (I); Exelixis (I); Genentech/Roche (I); Helio Health (I); Incyte (I); Ipsen; Merck; Novartis; QED Therapeutics (I); Yiviva (I); Yiviva (I)
Research Funding - Arcus Ventures (Inst); AstraZeneca/MedImmune (Inst); BioNTech (Inst); Bristol Myers Squibb (Inst); Bristol Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Helsinn Healthcare (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst); Roche (Inst); Yiviva (Inst)
(OPTIONAL) Uncompensated Relationships - Thetis Pharma
 
Jeffrey A. Meyerhardt
Honoraria - Merck
Research Funding - Boston Biomedical (Inst)
 
Amylou C. Dueck
No Relationships to Disclose
 
Ethan Basch
Consulting or Advisory Role - AstraZeneca; Navigating Cancer; Resilience Care; SIVAN Innovation
Other Relationship - American Society of Clinical Oncology; Centers for Medicare and Medicaid Services; JAMA-Journal of the American Medical Association; National Cancer Institute; Patient-Centered OUtcomes Research Institute (PCORI)
 
George J. Chang
Consulting or Advisory Role - Medicaroid
 
Harvey J. Mamon
Honoraria - UpToDate
Consulting or Advisory Role - Merck Sharp & Dohme